Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.
NGUIPDOP-DJOMO, P; Heldal, E; RODRIGUES, LC; Abubakar, I; MANGTANI, P;
2015
The Lancet infectious diseases, (2015).16 2 10.1016/S1473-3099(15)00400-4.
Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.
ROCA, A; BOJANG, A; BOTTOMLEY, C; Gladstone, RA; Adetifa, JU; Egere, U; BURR, S; ANTONIO, M; Bentley, S; KAMPMANN, B; Pneumo13 Study Group,;
2015
Vaccine, (2015).33 51 10.1016/j.vaccine.2015.11.012.
The PneuCarriage Project: A Multi-Centre Comparative Study to Identify the Best Serotyping Methods for Examining Pneumococcal Carriage in Vaccine Evaluation Studies.
Satzke, C; Dunne, EM; Porter, BD; Klugman, KP; MULHOLLAND, EK; PneuCarriage project group,;
2015
PLoS medicine, (2015).12 11 10.1371/journal.pmed.1001903.
Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.
RHODES, SJ; KNIGHT, GM; FIELDING, K; Scriba, TJ; Pathan, AA; McShane, H; FLETCHER, H; WHITE, RG;
2015
Tuberculosis (Edinburgh, Scotland), (2015).96, 10.1016/j.tube.2015.10.002.
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.
Penny, MA; Verity, R; Bever, CA; Sauboin, C; Galactionova, K; FLASCHE, S; White, MT; Wenger, EA; Van de Velde, N; Pemberton-Ross, P; Griffin, JT; Smith, TA; Eckhoff, PA; Muhib, F; JIT, M; Ghani, AC;
2015
Lancet, (2015).387 10016 10.1016/S0140-6736(15)00725-4.
Implementation of the malaria candidate vaccine RTS,S/AS01.
GREENWOOD, B; Doumbo, OK;
2015
Lancet, (2015).387 10016 10.1016/S0140-6736(15)00807-7.
PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia.
Binks, MJ; Moberley, SA; Balloch, A; Leach, AJ; Nelson, S; Hare, KM; Wilson, C; Morris, PS; Nelson, J; Chatfield, MD; Tang, ML K; Torzillo, P; Carapetis, JR; MULHOLLAND, EK; Andrews, RM;
2015
Vaccine, (2015).33 48 10.1016/j.vaccine.2015.10.101.
Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.
Burton, DC; Bigogo, GM; Audi, AO; Williamson, J; Munge, K; Wafula, J; Ouma, D; Khagayi, S; Mugoya, I; Mburu, J; Muema, S; Bauni, E; Bwanaali, T; Feikin, DR; Ochieng, PM; Mogeni, OD; Otieno, GA; Olack, B; Kamau, T; Van Dyke, MK; Chen, R; Farrington, P; Montgomery, JM; Breiman, RF; SCOTT, JA G; ... Laserson, KF.
2015
PloS one, (2015).10 10 10.1371/journal.pone.0141896.
Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
Badamchi-Zadeh, A; McKay, PF; HOLLAND, MJ; Paes, W; Brzozowski, A; Lacey, C; Follmann, F; Tregoning, JS; Shattock, RJ;
2015
PloS one, (2015).10 10 10.1371/journal.pone.0141209.
A systematic review of the social and economic burden of influenza in low- and middle-income countries.
De Francisco Shapovalova, N; Donadel, M; JIT, M; Hutubessy, R;
2015
Vaccine, (2015).33 48 10.1016/j.vaccine.2015.10.066.